UnknownPhase 4

Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome

120 participantsStarted 2020-10-01

Plain-language summary

Compare the efficacy and safety of endovascular treatment with sandwich technique (controlled release coils and 2% polidocanol foam) associated with diosmin-hisperidine and ibuprofen medical treatment and only the best chronic medical treatment available diosmin-hisperidine and ibuprofen for 3 months, in women of active gynecological age carrying pelvic congestion syndrome in public assistance in Montevideo, Uruguay.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Active gynecological age * Chronic pelvic pain diagnosed by gynecologist of at least 6 months of evolution. * Transvaginal duplex ultrasound: presence of periuterine varicose veins defined by veins larger than 5mm in diameter with reflux greater than 0.5 seconds on Valsava maneuvers. Exclusion Criteria: * Presence of other causes of chronic pelvic pain: endometriosis, pelvic inflammatory disease, postoperative adhesions, uterine myoma, adenomyosis, ovarian tumors, polycystic ovary. * Fibromyalgia * BMI greater than 35 * Chronic kidney disease * thrombophilia * Alterationof coagulation. * Allergy to iodinated contrast medium.

What they're measuring

visual analogue scale (VAS)

Timeframe: 30 days

visual analogue scale (VAS)

Timeframe: 3 months

Lattinen index

Timeframe: 30 days

Lattinen index

Timeframe: 3 months

McGill Pain Questionnaire

Timeframe: 30 days

McGill Pain Questionnaire

Timeframe: 3 months

Trial details

NCT IDNCT04358497

SponsorHospital de Clínicas Dr. Manuel Quintela

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-31

Contact for this trial

Sebastian Sarutte, VS

+59899533449 ssarutte1@hotmail.com

View on ClinicalTrials.gov More Pelvic Congestive Syndrome trials